Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
John T. Treace, a principal officer and director of TREACE MEDICAL CONCEPTS, INC., recently acquired a significant block of the company's common stock. This transaction occurred while the stock was experiencing substantial gains. Furthermore, recent corporate disclosures included financial results for the first quarter of 2026 that surpassed analys…
Robert D. Fatovic, an executive at Ryder System Inc., sold a significant block of common stock on May 29, 2026. This transaction occurred while the company's stock price was near its 52-week high and shortly after reporting Q1 2026 earnings that beat profit estimates but slightly missed revenue forecasts.
Bettina Deynes, Chief Human Resources Officer at Carnival Corp Ltd., sold a significant block of common shares. This transaction occurs against a backdrop of several positive corporate developments for the company, including a dividend announcement, structural unification, and favorable analyst actions that suggest potential undervaluation.
The Chief Legal Officer of Precigen Inc. recently sold a portion of company stock in a transaction defined as 'sell-to-cover.' This activity occurred against a backdrop of strong corporate performance, including Q1 2026 earnings that beat expectations, and significant regulatory news regarding the drug PAPZIMEOS.
Genworth Holdings sold a substantial block of shares in its investment, Enact Holdings. This transaction occurred while Enact reported mixed first-quarter earnings for 2026. Although the company surpassed consensus estimates for adjusted earnings per share (EPS), revenue fell below anticipated levels, prompting analysts to adjust price targets.
The Chief Executive Officer of Precigen, Inc., Helen Sabzevari, recently sold a significant block of company stock. This transaction occurred as the firm reported strong first-quarter financial results, including an earnings per share (EPS) figure that surpassed analyst expectations. Furthermore, the company secured a seven-year market advantage fo…
CTO Realty Growth has sold its Madison Yards grocery-anchored shopping center in Atlanta for $73.3 million as part of its capital recycling strategy to invest in higher-yielding properties. Concurrently, CTO is acquiring a power center in the Dallas metro area for approximately $53 million, strengthening its portfolio in high-growth Southeast and S…
Colombia posted a 1.5% year-on-year rise in oil production for April to 724,910 barrels per day, yet output fell 2.1% from March. Commercialized gas production declined 14.2% year-on-year to 694 million cubic feet per day and was also lower than March, according to the National Hydrocarbons Agency, which offered no explanation for the shifts.
A recent transaction involving director Wilfred T. O’Gara saw the sale of 10,369 common shares of LSI Industries Inc. (NASDAQ:LYTS) on June 1, 2026. The total value realized from this sale was $249,789, with each share priced at $24.09.This transaction occurred after a strong performance period for the company, which has seen its shares deliver a 5…
Covenant Logistics Group reported robust Q1 2026 financial results, with revenue exceeding expectations. This positive performance coincided with an executive selling a portion of his holdings, while external analysts raised price targets based on improvements in the truck market sector. The company also declared a quarterly dividend.
Ross Kade, Chief Information Officer at Bandwidth Inc., recently sold a portion of his company shares following the vesting of Restricted Stock Units (RSUs). This insider activity occurred against a backdrop of strong Q1 2026 earnings reports for Bandwidth, which beat analyst expectations. Despite the stock trading near its 52-week high and being f…
Devin M. Krupka, the Controller and Principal Accounting Officer at Bandwidth Inc., executed multiple sales of company stock totaling 1,198 shares valued at $70,496 on May 29, 2026. These transactions occurred while the stock was trading near its recent highs. The selling activity is noted against a backdrop of robust corporate performance, includi…
Novartis reported early findings from a 101-patient study of an experimental actinium-225 radioligand therapy showing prostate-specific antigen (PSA) declines in multiple patient cohorts, including those previously treated with Pluvicto. While response rates were notable, analysts and company executives emphasized the importance of managing side ef…
Jack Abuhoff, the Chief Executive Officer of Innodata Inc., executed a significant sale of common stock totaling approximately $10.9 million on May 29, 2026, following the exercise of his vested options. This activity occurs as Innodata shares trade near their recent 52-week high. The report also details that the company recently reported strong fi…
A range of companies across technology and biopharma saw pronounced after-hours stock moves following quarterly results and regulatory developments. Hewlett Packard Enterprise jumped after a strong quarter and aggressively raised guidance, Credo Technology slid despite an earnings beat, Fulcrum Therapeutics plunged after halting a sickle cell progr…
A director of Richmond Mutual Bancorporation, Inc., Blum E. Michael, recently acquired a block of common stock. This activity occurs against a backdrop of corporate development, including the announcement of a quarterly cash dividend and progress updates regarding the potential merger with The Farmers Bancorp of Frankfort, Indiana.
Chief Legal Officer Deborah Ann Miller sold a significant block of shares in Nuvalent, Inc. (NASDAQ:NUVL) via an established trading plan. This insider activity is reported alongside substantial positive developments regarding the company's drug pipeline, including the FDA granting Priority Review to neladalkib and presentation of updated data for …
Chief Commercial Officer Phil Tennant sold a portion of his holdings in PRECIGEN, INC. (PGEN) following vesting of restricted stock units. This transaction occurs amidst significant operational developments for the company, including better-than-expected Q1 2026 earnings and the granting of orphan drug exclusivity for PAPZIMEOS.
Independent Bank Corp. (INDB) reported robust first-quarter financial results, with revenue significantly exceeding consensus estimates. Concurrently, Joseph C. Lerner, a director at the bank, executed a transaction selling a notable block of company common stock, which was noted in recent filings. The sale occurred amidst reports detailing the ins…
The recent SEC filing revealed that Harry Thomasian Jr., Chief Financial Officer of Precigen, Inc. (PGEN), sold shares totaling $182,614 on May 28, 2026. This sale was specifically categorized as a 'sell-to-cover' transaction to satisfy tax withholding requirements related to the vesting of restricted stock units that occurred on May 23, 2026. Sepa…
Figure Technology Solutions CFO Kgil Minchung sold a substantial block of company shares, while the firm simultaneously released Q1 2026 earnings that beat analyst expectations on both profit and revenue. The report details executive trading activity alongside significant operational performance metrics.
Xometry, Inc., a U.S.-based AI-native custom manufacturing marketplace, has announced the commencement of a $225 million underwritten public offering of its Class A common stock, with a 30-day option for the underwriters to purchase an additional $33.75 million in shares. The net proceeds will be used for working capital and general corporate purpo…
Microchip Technology saw its stock climb about 7% in after-hours trading following a forecast that its Data Center Solutions Business Unit will grow roughly 65% to around $500 million in calendar year 2026. The unit produced $302.7 million in revenue in 2025 and posted a 62.9% year-over-year increase in the March 2026 quarter. The company also anno…
Abivax shares climbed 20% after the company reported that its Phase 3 ABTECT maintenance trial for obefazimod met the primary endpoint. Both 25 mg and 50 mg once-daily doses produced markedly higher clinical remission rates at Week 44 versus placebo, and the trial met all key secondary endpoints with no new safety signals reported over the 44-week …
The Chief Operating Officer of Precigen, Inc., Rutul R. Shah, recently sold a portion of his company stock in a tax-related transaction. This activity occurs against a backdrop of positive corporate developments, including exceeding market expectations for Q1 2026 earnings and securing significant drug exclusivity for PAPZIMEOS.
